高龄高危前列腺增生症的临床特点与经尿道等离子体电切术

The clinical character of senile high risk bnign prostate hyperplasia and transurethral plasmakinetic resection of prostate

目的探讨高龄高危前列腺增生症(BPH)的临床特点及经尿道等离子体电切术(PKRP)的安全性和有效性。方法在内科麻醉科的协助下,术前积极处理并发症和合并症,将手术风险降低至最低限度后再行PKRP。结果本组48例安全实施PKRP,随访6-12个月,排尿通畅,国际前列腺症状评分(IPSS)由30、5降到9、5分;生活质量评分(QOL)由6分降到2、5;残余尿(PVR)由186m l降至30m l,无水中毒、尿失禁及继发性出血。尿道狭窄2例。治疗后IP-SS、QOL、PVR差异有统计学意义。结论PKRP是治疗高龄高危BPH安全有效的方法。

Objective To evaluate the clinical character of senile high risk benign prostate hyperplasia and the safety and effect of transurethral plasmakinetic resection of prostate （PKRP）. Methods With the assistance of the department of internal medicine and anesthesia, we actively treated the complications preoperatively, minimize the risk of operation, then performed PKRP. Results Total 48 patients underwent PKRP safely, with follow - up 6 ～ 12 months, all with fluent urination, the International Prostate Symptom Score （IPSS） were decreased from 30.5 to 9.5, Quality of Life （QOL） decreased from 6.0 to 2.5, prostate volume reduction （PVR） decreased from 186 ml to 30 ml, without overhydration, uri- nary incontinence or secondary hemorrhage, with urethral stricture in 2 cases. The differences of IPS S, QOL and PVR between preoperatively and postoperatively have statistic significance. Conclusion PKRP is a safe and effective therapy to senile high risk benign prostate hyperplasia.